ClinConnect ClinConnect Logo
Search / Trial NCT06126809

Causal Role of the Aperiodic Signal for Working Memory

Launched by FLORIDA STATE UNIVERSITY · Nov 9, 2023

Trial Information

Current as of July 21, 2025

Recruiting

Keywords

Cognitive Control Working Memory Electroencephalography Transcranial Electrical Stimulation

ClinConnect Summary

This clinical trial is studying how a specific brain signal, called the aperiodic signal, affects working memory (WM), which is our ability to hold and use information in our minds without any outside help. Previous research has shown that certain brain activities are linked to how well we can use our working memory, but it’s not clear which signals are the most important. The goal of this study is to better understand the role of the aperiodic signal in helping with tasks that require working memory.

If you are between 18 and 35 years old, can see normally (or with glasses), and can understand English, you might be eligible to participate. However, people with certain conditions like ADHD, neurological disorders, or previous brain surgeries are not eligible. Participants will be asked to complete specific tasks while their brain activity is monitored. It’s important to know that this study is still recruiting participants, and those who join will need to commit to all study procedures. Your involvement could help researchers learn more about how the brain works and improve understanding of memory function.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Between the ages of 18 and 35
  • Able to provide informed consent
  • Normal or corrected-to-normal vision
  • Willing to comply with all study procedures and be available for the duration of the study
  • Ability to speak, read and understand English without a translator
  • Not color-blind
  • Exclusion Criteria:
  • ADHD/ADD (currently under treatment)
  • Neurological disorder and conditions
  • Medical or neurological illness or treatment for a medical disorder that could interfere with study participation, e.g., unstable cardiac disease, HIV/AIDS, malignancy, liver or renal impairment
  • Prior brain surgery
  • Any brain devices/implants, including cochlear implants and aneurysm clips
  • History of traumatic brain injury
  • (For females) Pregnant
  • Anything that, in the opinion of the investigator, would place the participant at increased risk or preclude the participant's full compliance with or completion of the study
  • Current use of medications know to produce specific EEG activity known to disrupt interpretations of the findings including but not limited to: benzodiazepines, antipsychotics, antiepileptics and central nervous system stimulants

About Florida State University

Florida State University (FSU) is a prestigious public research institution located in Tallahassee, Florida, known for its commitment to advancing knowledge and innovation in various fields, including health sciences. As a clinical trial sponsor, FSU leverages its extensive academic resources and expertise to conduct rigorous research aimed at improving patient outcomes and contributing to the medical community. The university fosters a collaborative environment that brings together multidisciplinary teams to design, implement, and analyze clinical studies, ensuring adherence to the highest ethical and scientific standards. Through its clinical trials, FSU aims to address critical health challenges and translate research findings into practical applications that benefit society.

Locations

Tallahassee, Florida, United States

Patients applied

0 patients applied

Trial Officials

Justin Riddle, PhD

Principal Investigator

Florida State University

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported